Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Vaccines targeting Staphylococcus aureus skin and bloodstream infections require different composition.

Luna BM, Nielsen TB, Cheng B, Pantapalangkoor P, Yan J, Boyle-Vavra S, Bruhn KW, Montgomery C, Spellberg B, Daum R.

PLoS One. 2019 Jun 10;14(6):e0217439. doi: 10.1371/journal.pone.0217439. eCollection 2019.

2.

"A Reliability Study Using Network-Oriented Research Assistant (NORA®) to Evaluate the Use of Digital Photographs in the Assessment of Atopic Dermatitis".

Hughes ME, Aralis H, Bruhn KW, Cotliar J, Craft N, DeLuca IJ, Hamidi R, Nguyen K, Patel M, Patel VA, Sofen H, Tan BH, David CV.

J Am Acad Dermatol. 2019 Jan 28. pii: S0190-9622(19)30150-1. doi: 10.1016/j.jaad.2019.01.043. [Epub ahead of print] No abstract available.

PMID:
30703454
3.

A reliability study using Network Oriented Research Assistant (NORA® ) examining the use of digital photographs in the assessment of psoriasis.

Jeong D, Aralis H, Bruhn KW, Cotliar J, Craft N, DeLuca IJ, Hamidi R, Nguyen K, Patel VA, Sofen H, Tan BH, David CV.

Br J Dermatol. 2019 Jan 31. doi: 10.1111/bjd.17702. [Epub ahead of print] No abstract available.

PMID:
30703265
4.

Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis.

Nielsen TB, Pantapalangkoor P, Luna BM, Bruhn KW, Yan J, Dekitani K, Hsieh S, Yeshoua B, Pascual B, Vinogradov E, Hujer KM, Domitrovic TN, Bonomo RA, Russo TA, Lesczcyniecka M, Schneider T, Spellberg B.

J Infect Dis. 2017 Aug 15;216(4):489-501. doi: 10.1093/infdis/jix315.

5.

Long-term exposure of MCF-7 breast cancer cells to ethanol stimulates oncogenic features.

Gelfand R, Vernet D, Bruhn KW, Sarkissyan S, Heber D, Vadgama JV, Gonzalez-Cadavid NF.

Int J Oncol. 2017 Jan;50(1):49-65. doi: 10.3892/ijo.2016.3800. Epub 2016 Dec 9.

6.

Ly6G-mediated depletion of neutrophils is dependent on macrophages.

Bruhn KW, Dekitani K, Nielsen TB, Pantapalangkoor P, Spellberg B.

Results Immunol. 2015 Dec 21;6:5-7. doi: 10.1016/j.rinim.2015.12.001. eCollection 2016.

7.

Cryopreservation of virulent Acinetobacter baumannii to reduce variability of in vivo studies.

Nielsen TB, Bruhn KW, Pantapalangkoor P, Junus JL, Spellberg B.

BMC Microbiol. 2015 Nov 2;15:252. doi: 10.1186/s12866-015-0580-8.

8.

The Potent Humanin Analogue (HNG) Protects Germ Cells and Leucocytes While Enhancing Chemotherapy-Induced Suppression of Cancer Metastases in Male Mice.

Lue Y, Swerdloff R, Wan J, Xiao J, French S, Atienza V, Canela V, Bruhn KW, Stone B, Jia Y, Cohen P, Wang C.

Endocrinology. 2015 Dec;156(12):4511-21. doi: 10.1210/en.2015-1542. Epub 2015 Sep 18.

9.

Transferrin-mediated iron sequestration as a novel therapy for bacterial and fungal infections.

Bruhn KW, Spellberg B.

Curr Opin Microbiol. 2015 Oct;27:57-61. doi: 10.1016/j.mib.2015.07.005. Epub 2015 Aug 9. Review.

10.

Host fate is rapidly determined by innate effector-microbial interactions during Acinetobacter baumannii bacteremia.

Bruhn KW, Pantapalangkoor P, Nielsen T, Tan B, Junus J, Hujer KM, Wright MS, Bonomo RA, Adams MD, Chen W, Spellberg B.

J Infect Dis. 2015 Apr 15;211(8):1296-305. doi: 10.1093/infdis/jiu593. Epub 2014 Nov 5.

11.

Topical resiquimod protects against visceral infection with Leishmania infantum chagasi in mice.

Craft N, Birnbaum R, Quanquin N, Erfe MC, Quant C, Haskell J, Bruhn KW.

Clin Vaccine Immunol. 2014 Sep;21(9):1314-22. doi: 10.1128/CVI.00338-14. Epub 2014 Jul 16.

12.

Transferrin iron starvation therapy for lethal bacterial and fungal infections.

Lin L, Pantapalangkoor P, Tan B, Bruhn KW, Ho T, Nielsen T, Skaar EP, Zhang Y, Bai R, Wang A, Doherty TM, Spellberg B.

J Infect Dis. 2014 Jul 15;210(2):254-64. doi: 10.1093/infdis/jiu049. Epub 2014 Jan 19.

13.

Myostatin genetic inactivation inhibits myogenesis by muscle-derived stem cells in vitro but not when implanted in the mdx mouse muscle.

Tsao J, Vernet DA, Gelfand R, Kovanecz I, Nolazco G, Bruhn KW, Gonzalez-Cadavid NF.

Stem Cell Res Ther. 2013 Jan 7;4(1):4. doi: 10.1186/scrt152.

14.

Oxidized low-density lipoprotein antigen transport induces autoimmunity in the renal tubulointerstitium.

Satirapoj B, Bruhn KW, Nast CC, Wang Y, Dai T, Lapage J, Wu X, Natarajan R, Adler SG.

Am J Nephrol. 2012;35(6):520-30. doi: 10.1159/000338484. Epub 2012 May 25.

15.

Killed but metabolically active Leishmania infantum as a novel whole-cell vaccine for visceral leishmaniasis.

Bruhn KW, Birnbaum R, Haskell J, Vanchinathan V, Greger S, Narayan R, Chang PL, Tran TA, Hickerson SM, Beverley SM, Wilson ME, Craft N.

Clin Vaccine Immunol. 2012 Apr;19(4):490-8. doi: 10.1128/CVI.05660-11. Epub 2012 Feb 8.

16.

Delineation of antigen-specific and antigen-nonspecific CD8(+) memory T-cell responses after cytokine-based cancer immunotherapy.

Tietze JK, Wilkins DE, Sckisel GD, Bouchlaka MN, Alderson KL, Weiss JM, Ames E, Bruhn KW, Craft N, Wiltrout RH, Longo DL, Lanier LL, Blazar BR, Redelman D, Murphy WJ.

Blood. 2012 Mar 29;119(13):3073-83. doi: 10.1182/blood-2011-07-369736. Epub 2012 Jan 17.

17.

Efficacy of synthetic peptides RP-1 and AA-RP-1 against Leishmania species in vitro and in vivo.

Erfe MC, David CV, Huang C, Lu V, Maretti-Mira AC, Haskell J, Bruhn KW, Yeaman MR, Craft N.

Antimicrob Agents Chemother. 2012 Feb;56(2):658-65. doi: 10.1128/AAC.05349-11. Epub 2011 Nov 28.

18.

Immunomodulation by imiquimod in patients with high-risk primary melanoma.

Narayan R, Nguyen H, Bentow JJ, Moy L, Lee DK, Greger S, Haskell J, Vanchinathan V, Chang PL, Tsui S, Konishi T, Comin-Anduix B, Dauphine C, Vargas HI, Economou JS, Ribas A, Bruhn KW, Craft N.

J Invest Dermatol. 2012 Jan;132(1):163-9. doi: 10.1038/jid.2011.247. Epub 2011 Aug 18.

19.

A critical role for GRP78/BiP in the tumor microenvironment for neovascularization during tumor growth and metastasis.

Dong D, Stapleton C, Luo B, Xiong S, Ye W, Zhang Y, Jhaveri N, Zhu G, Ye R, Liu Z, Bruhn KW, Craft N, Groshen S, Hofman FM, Lee AS.

Cancer Res. 2011 Apr 15;71(8):2848-57. doi: 10.1158/0008-5472.CAN-10-3151. Epub 2011 Apr 5.

20.

LXR deficiency confers increased protection against visceral Leishmania infection in mice.

Bruhn KW, Marathe C, Maretti-Mira AC, Nguyen H, Haskell J, Tran TA, Vanchinathan V, Gaur U, Wilson ME, Tontonoz P, Craft N.

PLoS Negl Trop Dis. 2010 Nov 16;4(11):e886. doi: 10.1371/journal.pntd.0000886.

21.

Enhanced antitumor activity induced by adoptive T-cell transfer and adjunctive use of the histone deacetylase inhibitor LAQ824.

Vo DD, Prins RM, Begley JL, Donahue TR, Morris LF, Bruhn KW, de la Rocha P, Yang MY, Mok S, Garban HJ, Craft N, Economou JS, Marincola FM, Wang E, Ribas A.

Cancer Res. 2009 Nov 15;69(22):8693-9. doi: 10.1158/0008-5472.CAN-09-1456. Epub 2009 Oct 27.

22.

Galectin-1 tunes TCR binding and signal transduction to regulate CD8 burst size.

Liu SD, Tomassian T, Bruhn KW, Miller JF, Poirier F, Miceli MC.

J Immunol. 2009 May 1;182(9):5283-95. doi: 10.4049/jimmunol.0803811.

23.

Immunosensitization with a Bcl-2 small molecule inhibitor.

Begley J, Vo DD, Morris LF, Bruhn KW, Prins RM, Mok S, Koya RC, Garban HJ, Comin-Anduix B, Craft N, Ribas A.

Cancer Immunol Immunother. 2009 May;58(5):699-708. doi: 10.1007/s00262-008-0592-4. Epub 2008 Sep 20.

PMID:
18807035
24.

Listeria as a vaccine vector.

Bruhn KW, Craft N, Miller JF.

Microbes Infect. 2007 Aug;9(10):1226-35. Epub 2007 May 7. Review.

PMID:
17719258
25.

Central nervous system tumor immunity generated by a recombinant listeria monocytogenes vaccine targeting tyrosinase related protein-2 and real-time imaging of intracranial tumor burden.

Prins RM, Bruhn KW, Craft N, Lin JW, Kim CH, Odesa SK, Miller JF, Liau LM.

Neurosurgery. 2006 Jan;58(1):169-78; discussion 169-78.

PMID:
16385341
26.

The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity.

Prins RM, Craft N, Bruhn KW, Khan-Farooqi H, Koya RC, Stripecke R, Miller JF, Liau LM.

J Immunol. 2006 Jan 1;176(1):157-64.

27.

The TLR7 agonist imiquimod enhances the anti-melanoma effects of a recombinant Listeria monocytogenes vaccine.

Craft N, Bruhn KW, Nguyen BD, Prins R, Lin JW, Liau LM, Miller JF.

J Immunol. 2005 Aug 1;175(3):1983-90.

28.

Bioluminescent imaging of melanoma in live mice.

Craft N, Bruhn KW, Nguyen BD, Prins R, Liau LM, Collisson EA, De A, Kolodney MS, Gambhir SS, Miller JF.

J Invest Dermatol. 2005 Jul;125(1):159-165. doi: 10.1111/j.0022-202X.2005.23759.x.

29.

Characterization of anti-self CD8 T-cell responses stimulated by recombinant Listeria monocytogenes expressing the melanoma antigen TRP-2.

Bruhn KW, Craft N, Nguyen BD, Yip J, Miller JF.

Vaccine. 2005 Jul 21;23(33):4263-72. Epub 2005 Mar 10.

PMID:
15913853
30.

LXR-dependent gene expression is important for macrophage survival and the innate immune response.

Joseph SB, Bradley MN, Castrillo A, Bruhn KW, Mak PA, Pei L, Hogenesch J, O'connell RM, Cheng G, Saez E, Miller JF, Tontonoz P.

Cell. 2004 Oct 15;119(2):299-309.

31.

Type I interferon production enhances susceptibility to Listeria monocytogenes infection.

O'Connell RM, Saha SK, Vaidya SA, Bruhn KW, Miranda GA, Zarnegar B, Perry AK, Nguyen BO, Lane TF, Taniguchi T, Miller JF, Cheng G.

J Exp Med. 2004 Aug 16;200(4):437-45. Epub 2004 Aug 9.

32.

Listeria monocytogenes as a vaccine vector: virulence attenuation or existing antivector immunity does not diminish therapeutic efficacy.

Starks H, Bruhn KW, Shen H, Barry RA, Dubensky TW, Brockstedt D, Hinrichs DJ, Higgins DE, Miller JF, Giedlin M, Bouwer HG.

J Immunol. 2004 Jul 1;173(1):420-7.

33.

Molecular dissection of the mouse interleukin-4 promoter.

Bruhn KW, Nelms K, Boulay JL, Paul WE, Lenardo MJ.

Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9707-11.

Supplemental Content

Loading ...
Support Center